Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Inverness Medical raises $3.4 million in sell-off:

This article was originally published in Clinica

Executive Summary

Inverness Medical Technology (formerly known as Selfcare) has sold its minority interest in Theratase, a UK producer of diagnostic enzymes, for £2.2 million ($3.4 million). The UK-based Inverness said that the disposal signifies its focus on blood glucose monitoring and diabetes related products. These are sold in the US through WalMart, Walgreens and other drugstore chains. The company also develops and manufactures proprietary glucose monitoring systems, marketed worldwide through the LifeScan subsidiary of Johnson & Johnson.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT076648

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel